Early psoriatic arthritis

Early psoriatic arthritis

Bibliographic Details
Main Authors:	E. Y. Loginova, T. V. Korotaeva
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2008-12-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/628

Similar Items

Clinical experience with apremilast for psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2018-09-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
by: T. V. Korotaeva, et al.
Published: (2015-10-01)

Janus kinase inhibitors in the treatment of psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2022-02-01)

Cardiovascular risk in patients with psoriatic arthritis
by: T V Korotaeva, et al.
Published: (2016-05-01)

Involvement of the axial skeleton in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2017-03-01)

Dactylitis in psoriatic arthritis: clinical features, diagnosis, immunopathogenesis, and treatment
by: T. V. Korotaeva, et al.
Published: (2018-04-01)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2015-09-01)

Comparative characteristics of early psoriatic arthritis with and without axial skeleton injury (a subanalysis of the all-Russian registry of patients with psoriatic arthritis)
by: E. E. Gubar, et al.
Published: (2019-12-01)

Results of studying the clinical efficacy and safety of tofacitinib in the treatment of psoriatic arthritis
by: T. V. Korotaeva, et al.
Published: (2019-05-01)

The duration of remission and minimal disease activity after initiation and discontinuation of biological agents in patients with early psoriatic arthritis (data from the all-russian psoriatic arthritis registry)
by: E. Yu. Loginova, et al.
Published: (2019-11-01)

Immunopathogenetic mechanisms of action of ustekinumab, a new drug for the treatment of psoriatic arthritis and psoriasis
by: T. V. Korotaeva, et al.
Published: (2015-06-01)

CLINICAL EXPERIENCE WITH USTEKINUMAB IN THE TREATMENT OF EARLY PSORIATIC ARTHRITIS USING TREAT-TO-TARGET STRATEGY
by: E. Yu. Loginova, et al.
Published: (2015-09-01)

Estimation of the sensitivity and specificity of ASAS criteria for peripheral spondyloarthritis in patients with early psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2015-09-01)

2-years outcomes of the treat-to-target strategy in early psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2022-11-01)

SYSTEMIC OSTEOPOROSIS AND PSORIATIC ARTHRITIS: CURRENT UNDERSTANDING OF THE PROBLEM
by: O. V. Dobrovolskaya, et al.
Published: (2017-10-01)

Experience in using secukinumab in patients with axial psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-11-01)

Time course of changes in lipid profile measures in patients with early psoriatic arthritis during adalimumab therapy
by: E. I. Markelova, et al.
Published: (2019-11-01)

Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study
by: T V Korotaeva, et al.
Published: (2018-05-01)

Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
by: E. E. Gubar, et al.
Published: (2021-10-01)

TREAT-TO-TARGET STRATEGY FOR EARLY PSORIATIC ARTHRITIS (PRELIMINARY RESULTS OF THE REMARCА STUDY)
by: T. V. Korotaeva, et al.
Published: (2016-12-01)

TREAT-TO-TARGET STRATEGY FOR EARLY PSORIATIC ARTHRITIS (PRELIMINARY RESULTS OF THE REMARCА STUDY)
by: T. V. Korotaeva, et al.
Published: (2014-09-01)

Psoriatic arthritis. Clinical guidelines for diagnosis and treatment
by: T. V. Korotaeva, et al.
Published: (2018-06-01)

SPECIFIC FEATURES OF AXIAL SKELETON INVOLVEMENT IN EARLY PSORIATIC ARTHRITIS (The REMARCA TRIAL)
by: E. Yu. Loginova, et al.
Published: (2016-09-01)

DETECTION RATES OF PSORIATIC ARTHRITIS IN PATIENTS WITH PSORIASIS IN A DERMATOLOGY AND RHEUMATOLOGY CLINIC
by: M. N. Chamurlieva, et al.
Published: (2016-12-01)

Experience of guselkumab usage in the treatment of patients with psoriatic arthritis in real clinical practice
by: E. Yu. Loginova, et al.
Published: (2021-10-01)

Detectability of the peripheral and axial manifestations of psoriatic arthritis in patients with psoriasis in dermatological practice
by: M. N. Chamurlieva, et al.
Published: (2019-10-01)

Axial involvement in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2022-12-01)

Standards of therapy of psoriatic arthritis
by: T V Korotaeva, et al.
Published: (2009-06-01)

Etanercept (Enbrel) in the treatment of psoriatic arthritis
by: T V Korotaeva
Published: (2009-12-01)

SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS
by: E. E. Gubar, et al.
Published: (2018-11-01)

Modern pharmacotherapy of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2019-03-01)

CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF AXIAL LESION IN EARLY PERIPHERAL PSORIATIC ARTHRITIS (DATA OF A REMARCA STUDY)
by: E. E. Gubar, et al.
Published: (2018-03-01)

THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01)

Comparative characterization of the data of magnetic resonance imaging, X-ray and clinical studies of the hand and foot joints in patients with early psoriatic arthritis
by: Svetlana Olegovna Krasnenko, et al.
Published: (2013-04-01)

EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE
by: E. Yu. Loginova, et al.
Published: (2020-06-01)

Use of a multidimensional RAPID3 questionnaire to assess the achievement of remission and minimal disease activity in patients with early psoriatic arthritis treated according to Treat-to-target strategy
by: E. Yu. Loginova, et al.
Published: (2019-01-01)

Possibilities of screening for a high-risk axial skeletal lesion in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-09-01)

PSORIATIC ARTHRITIS: CLASSIFICATION, CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT
by: T. V. Korotaeva
Published: (2014-12-01)

The first results of a 6-year follow-up study of a patient with early psoriatic arthritis treated with a treat-to-target strategy
by: P. O. Tremaskina, et al.
Published: (2020-09-01)

Characteristics of patients with psoriatic arthritis treated with ustekinumab. Evidence from real-life clinical practice
by: Yu. L. Korsakova, et al.
Published: (2021-01-01)